HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A double-blind controlled trial of salmon calcitonin in pain due to malignancy.

Abstract
Thirty-two patients with established malignancy and associated pain participated in a randomised double-blind controlled trial. They received salmon calcitonin SC 200 UI or matching placebo 6-hourly for 48 h and were assessed by using a combination of a 20-point visual analogue scale (VAS), a 4-point physician's global pain scale, and ranking of the co-administered analgesics into 20 grades of potency. Twenty-five patients (13 calcitonin, 12 placebo) were evaluated. Seven patients (4 calcitonin, 3 placebo) were excluded either because the initial pain score was less than or equal to 5 on the VAS, or because there were insufficient data (due to death occurring within the first week of the study or, in one patient, blindness preventing completion of the VAS). One week after commencing therapy there was improvement or marked improvement of pain in significantly more patients in the calcitonin group (5/13) than in the placebo group (0/12) (Fisher's exact two-tailed probability test, P = 0.0484). At the end of the second week three patients in the calcitonin group were still showing marked improvement.
AuthorsA C Hindley, E B Hill, M J Leyland, A E Wiles
JournalCancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 9 Issue 2 Pg. 71-4 ( 1982) ISSN: 0344-5704 [Print] Germany
PMID6756666 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Calcitonin
Topics
  • Calcitonin (therapeutic use)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Humans
  • Neoplasms (complications)
  • Pain (drug therapy, etiology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: